Reidenberg M M
Department of Pharmacology, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York, USA.
Clin Pharmacol Ther. 2007 Apr;81(4):603-6. doi: 10.1038/sj.clpt.6100106. Epub 2007 Feb 21.
The WHO program on essential medicines advises governments about how to determine which medicines are needed to meet the health care needs of the majority of the population and how to make them available to everyone. A Model List of these medicines proposed in 1977 included 186 drugs; the current list exceeds 300. The principle of making essential medicines available to everyone is accepted by 156 countries. Implementation is variable. Problems currently being considered for solution include whether drugs effective for rare diseases are ever essential and getting pediatric dosage forms of essential drugs manufactured and registered for sale. With all societies dealing with the rising cost of medical care and having to make choices, the concept of essential medicines is a relevant to all now as it was to countries with limited resources when the WHO program started in 1975.
世界卫生组织基本药物计划就如何确定满足大多数人口医疗保健需求所需的药物以及如何让每个人都能获得这些药物向各国政府提供建议。1977年提出的这些药物的示范清单包括186种药物；目前的清单超过300种。向每个人提供基本药物的原则已被156个国家接受。实施情况各不相同。目前正在考虑解决的问题包括对罕见病有效的药物是否永远是必需的，以及生产基本药物的儿科剂型并注册销售。鉴于所有社会都在应对不断上涨的医疗费用并不得不做出选择，基本药物的概念现在对所有国家都很重要，就像1975年世界卫生组织计划启动时对资源有限的国家一样重要。
